Literature DB >> 34604919

Blood Flow Diversion Within Hepatocellular Carcinoma (HCC) after Selective Occlusion of Feeding Arteries (SOFA) and Feasibility of Utilizing the SOFA Technique in Transarterial Chemoembolization (SOFA-TACE).

Simon Chun Ho Yu1.   

Abstract

PURPOSE: Arterial feeders supplying a hepatocellular carcinoma are known to be interconnected through the sinusoid-like tumor vasculature. It was observed angiographically that when one of the feeders is selectively catheterized for drug delivery in transarterial chemoembolization (TACE), the whole tumor vasculature will be filled up, if the arterial inflow from all the other feeders is temporarily arrested with selective occlusion of feeding arteries (SOFA) using an additional catheter (balloon catheter). The feasibility of using the SOFA technique in TACE (SOFA-TACE) is discussed.
MATERIALS AND METHODS: In this prospective, monocentric feasibility study, with informed consent obtained, 8 consecutive patients of median age 64.5 years (60-68.8) and tumor dimension 4.7 cm (3.2-6.1), having specific tumor features (solitary, hypervascularity, well-defined, ≤ 7 cm, multiple tumor feeders), received SOFA-TACE using ethiodized oil-cisplatin suspension. Tumor response was assessed with 3-monthly CT using modified RECIST.
RESULTS: A single tumor feeder was catheterized for drug delivery (8 cases). All other tumor feeders were successfully occluded with a balloon at one site (8 cases). Complete filling of the vasculature of the whole tumor was achieved in 7 of 8 cases with the SOFA technique as shown on arteriogram and CT, except in a case with an intratumoral septum. There was no complication. Surveillance CT (median 25 months, range 22-28) showed complete response in all cases.
CONCLUSION: SOFA-TACE is feasible with reasonable safety and favorable treatment outcome; it may be a valuable technical option that may facilitate the procedures of selective TACE in technically challenging cases.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Entities:  

Keywords:  Angioarchitecture of hepatocellular carcinoma; Balloon-assisted chemoembolization; Selective chemoembolization; Selective temporary balloon occlusion; Transarterial treatment of hepatocellular carcinoma

Mesh:

Year:  2021        PMID: 34604919     DOI: 10.1007/s00270-021-02973-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  12 in total

1.  Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?

Authors:  Koichiro Yamakado; Shiro Miyayama; Shozo Hirota; Kimiyoshi Mizunuma; Kenji Nakamura; Yoshitaka Inaba; Akihiro Maeda; Kunihiro Matsuo; Norifumi Nishida; Takeshi Aramaki; Hiroshi Anai; Shinichi Koura; Shigeo Oikawa; Ken Watanabe; Taku Yasumoto; Kinya Furuichi; Masato Yamaguchi
Journal:  Jpn J Radiol       Date:  2012-05-30       Impact factor: 2.374

Review 2.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

3.  Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson.

Authors:  L Fournier; S Ammari; R Thiam; C-A Cuénod
Journal:  Diagn Interv Imaging       Date:  2014-06-17       Impact factor: 4.026

4.  Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.

Authors:  Toshiyuki Irie; Masashi Kuramochi; Nobuyuki Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  2012-09-21       Impact factor: 2.740

5.  Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.

Authors:  Atsushi Hiraoka; Takashi Kumada; Masatoshi Kudo; Masashi Hirooka; Yohei Koizumi; Yoichi Hiasa; Kazuto Tajiri; Hidenori Toyoda; Toshifumi Tada; Hironori Ochi; Koji Joko; Noritomo Shimada; Akihiro Deguchi; Toru Ishikawa; Michitaka Imai; Kunihiko Tsuji; Kojiro Michitaka
Journal:  Dig Dis       Date:  2017-10-17       Impact factor: 2.404

6.  Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography.

Authors:  K Ueda; O Matsui; Y Kawamori; Y Nakanuma; M Kadoya; J Yoshikawa; T Gabata; A Nonomura; T Takashima
Journal:  Radiology       Date:  1998-01       Impact factor: 11.105

Review 7.  Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy.

Authors:  Alessandro Vitale; Franco Trevisani; Fabio Farinati; Umberto Cillo
Journal:  Hepatology       Date:  2020-10-26       Impact factor: 17.425

8.  Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE.

Authors:  Toshiyuki Irie; Masashi Kuramochi; Toshiro Kamoshida; Nobuyuki Takahashi
Journal:  Hepatol Res       Date:  2015-09-02       Impact factor: 4.288

9.  Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.

Authors:  Pierleone Lucatelli; Luca Ginnani Corradini; Gianluca De Rubeis; Bianca Rocco; Fabrizio Basilico; Alessandro Cannavale; Pier Giorgio Nardis; Mario Corona; Luca Saba; Carlo Catalano; Mario Bezzi
Journal:  Cardiovasc Intervent Radiol       Date:  2019-03-06       Impact factor: 2.740

Review 10.  Ultraselective conventional transarterial chemoembolization: When and how?

Authors:  Shiro Miyayama
Journal:  Clin Mol Hepatol       Date:  2019-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.